AF
MLNT

Advisornet Financial’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Advisornet Financial’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-40
Closed – – 2028
2019
Q4 		$0 Hold
40
– – ﹤0.01% 2063
2019
Q3 		$0 Hold
40
– – ﹤0.01% 2021
2019
Q2 		$0 Hold
40
– – ﹤0.01% 1845
2019
Q1 		$0 Hold
40
– – ﹤0.01% 1705
2018
Q4 		$0 Hold
40
– – ﹤0.01% 1622
2018
Q3 		$1K Hold
40
– – ﹤0.01% 1443
2018
Q2 		$1K Hold
40
– – ﹤0.01% 1543
2018
Q1 		$1K Hold
40
– – ﹤0.01% 1383
2017
Q4 		$3K Buy
+40
New +$2.96K ﹤0.01% 1162

Advisornet Financial's MLNT Position: Q1 2020 in Review

Advisornet Financial sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 40 shares.

Advisornet Financial first reported a position in MLNT in Q4 2017 and held it in 9 quarters. The position peaked at $3K in Q4 2017. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

  • Advisornet Financial reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Advisornet Financial sold 40 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020.
  • Advisornet Financial first reported a position in Melinta Therapeutics, Inc. Common Stock in Q4 2017 and held it in 9 quarters.
  • Advisornet Financial's Melinta Therapeutics, Inc. Common Stock position peaked at $3K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Advisornet Financial's 13F filing for Q1 2020, filed 14 May 2020.